carbamazepine has been researched along with Intellectual Disability in 67 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine is an anticonvulsant and psychotropic medication commonly used in the treatment of people with intellectual disability (ID)." | 7.71 | Hyponatremia during carbamazepine therapy in patients with intellectual disability. ( Hillery, J; Kelly, BD, 2001) |
| "In utero exposure to carbamazepine may result in 'carbamazepine syndrome' characterised by facial dysmorphic features and mild mental retardation." | 7.69 | Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. ( Cohen, E; Ornoy, A, 1996) |
| "Carbamazepine-induced hyponatremia has been reported in 21." | 7.68 | Carbamazepine-induced hyponatremia in patients with mental retardation. ( Friedman, DL; Kastner, T; Pond, WS, 1992) |
| "Oxcarbazepine appears to be an effective and well-tolerated drug for children and adolescents with intellectual disability and epilepsy." | 6.69 | Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. ( Gaily, E; Granström, ML; Liukkonen, E, 1998) |
| " The bioavailability of CBZ from the two preparations was similar." | 6.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| "Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures." | 6.40 | Carbamazepine in the treatment of epilepsy in people with intellectual disability. ( Alvarez, N; Waisburg, H, 1998) |
| "Under the medicine treatment of magnesium valproate with carbamazepine, the patient experienced partial seizures approximately once per month that lasted 30 to 60 seconds each without any complications observed during a follow-up period of 24 months." | 5.01 | A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report. ( Jiang, Z; Li, B; Li, J; Li, Y; Wang, L; Zhang, T, 2019) |
| "To investigate the effect of antiepileptic drugs, especially carbamazepine and valproate, on intelligence in prenatally exposed children of mothers with epilepsy." | 3.72 | Normal intelligence in children with prenatal exposure to carbamazepine. ( Bardy, A; Gaily, E; Granström, ML; Hiilesmaa, V; Isoaho, M; Kaaja, E; Kantola-Sorsa, E; Kotila, M; Matila, R; Nylund, T, 2004) |
| "Carbamazepine is an anticonvulsant and psychotropic medication commonly used in the treatment of people with intellectual disability (ID)." | 3.71 | Hyponatremia during carbamazepine therapy in patients with intellectual disability. ( Hillery, J; Kelly, BD, 2001) |
| "This single case reports an open trial of lamotrigine in the treatment of self-injurious behavior (SIB) and epilepsy in an 18-year-old female diagnosed with generalized seizure disorder, stereotypic movement disorder, and compulsive SIB in the context of profound mental retardation." | 3.69 | Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. ( Davanzo, PA; King, BH, 1996) |
| "In utero exposure to carbamazepine may result in 'carbamazepine syndrome' characterised by facial dysmorphic features and mild mental retardation." | 3.69 | Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. ( Cohen, E; Ornoy, A, 1996) |
| " Following treatment with antiepileptic drugs (AEDs), the patient developed several rare complications: after beginning therapy with phenytoin, the patient developed pseudolymphoma; after monotherapy with carbamazepine (CBZ), the patient thereafter developed myoclonic jerks of upper and lower limbs upon awakening; after one year of treatment with valproate (VPA) the patient developed clinical and immuno-haematological signs of SLE." | 3.69 | Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p. ( Diomedi, M; Gigli, GL; Masala, C; Placidi, F; Pomponi, MG; Scalise, A; Silvestri, G, 1996) |
| "Carbamazepine-induced hyponatremia has been reported in 21." | 3.68 | Carbamazepine-induced hyponatremia in patients with mental retardation. ( Friedman, DL; Kastner, T; Pond, WS, 1992) |
| "A girl was born to a mother who had undergone treatment for epilepsy with carbamazepine during pregnancy." | 3.68 | Teratogenic effect of carbamazepine. ( Vestermark, S; Vestermark, V, 1991) |
| "Oxcarbazepine appears to be an effective and well-tolerated drug for children and adolescents with intellectual disability and epilepsy." | 2.69 | Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. ( Gaily, E; Granström, ML; Liukkonen, E, 1998) |
| " The bioavailability of CBZ from the two preparations was similar." | 2.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| "Haloperidol was administered in standardized doses of ." | 2.66 | Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies. ( Aman, MG; Teehan, CJ; Turbott, SH; Vaithianathan, C; White, AJ, 1989) |
| "In patients with EAST syndrome, seizure is the first symptom occurring around 3-4 months of age." | 2.61 | Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10. ( Albaradie, R; Alhazmi, R; Alkhaldi, H; Chaudhary, M; Housawi, Y; Mir, A, 2019) |
| "Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures." | 2.40 | Carbamazepine in the treatment of epilepsy in people with intellectual disability. ( Alvarez, N; Waisburg, H, 1998) |
| "The carbamazepine studies were inconclusive." | 2.38 | Nonneuroleptic treatment of disruptive behavior in organic mental syndromes. ( Perry, PJ; Smith, DA, 1992) |
| "Self-injuring patients with borderline personality disorder may benefit from milieu treatment." | 2.38 | Self-injurious behavior: a review of the behavior and biology of self-mutilation. ( Stanley, M; Winchel, RM, 1991) |
| "To study the risk of intellectual disability and delayed development in childhood milestones among children of women who used valproate or other AEDs during pregnancy." | 1.56 | Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. ( Christensen, J; Daugaard, CA; Dreier, JW; Pedersen, L; Sun, Y, 2020) |
| "Epilepsy is common in individuals with autism spectrum disorder (ASD) and intellectual disabilities (ID)." | 1.42 | Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities. ( Katz, N; Moses, L; Weizman, A, 2015) |
| "For patients with mental retardation or developmental delay, 25(OH)D3 levels were lower than the levels in patients with normal intelligence quotient levels (p=0." | 1.40 | Vitamin D levels in children and adolescents with antiepileptic drug treatment. ( Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH, 2014) |
| "The prevalence of unrecognized primary hypothyroidism and hyperthyroidism was 5·2% and 2·8%, respectively." | 1.37 | Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study. ( de Rijke, YB; van Toor, H; Visser, TJ; Visser, WE, 2011) |
| "We recently encountered 2 cases of neuralgic amyotrophy in children." | 1.37 | MRI findings and steroid therapy for neuralgic amyotrophy in children. ( Mano, T; Suzuki, Y; Toribe, Y; Yamada, K; Yanagihara, K, 2011) |
| "We report on a 50-year-old man with mental retardation and right-sided hemi-paresis." | 1.32 | [Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient]. ( Huber, B; Seidel, M; Tomka-Hoffmeister, M, 2004) |
| "Carbamazepine was preferred to phenobarbital and phenytoin." | 1.29 | Neuroleptic and antiepileptic treatment in the mentally retarded. ( Brodtkorb, E; Sand, T; Strandjord, RE, 1993) |
| "Authors report about a boy with Rasmussen syndrome." | 1.29 | [Rasmussen syndrome]. ( Lombay, B; Velkey, I, 1993) |
| "A case of recurrent neuroleptic malignant syndrome (NMS) occurring in a 29-year-old man with mild mental handicap and a superadded psychotic disorder is described." | 1.28 | Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. ( Bambrick, M; Wilson, D, 1992) |
| "Carbamazepine treatment lowers the serum 25-OH-D concentration, and inactivity which leads to a lower degree of time spent out-of-doors and thus a low exposure to sunlight still decreases the concentration." | 1.28 | Vitamin D status of ambulatory and nonambulatory mentally retarded children with and without carbamazepine treatment. ( Grönlund, T; Lamberg-Allardt, C; Saraste, KL; Wilska, M, 1990) |
| "Most patients have quiescent seizure disorders and can manage well on monotherapy." | 1.27 | Reduction of polypharmacy for epilepsy in an institution for the retarded. ( Bennett, HS; Dunlop, T; Ziring, P, 1983) |
| "During an outbreak of pertussis in residents and staff of a facility for the developmentally disabled, 149 persons had laboratory evidence of Bordetella pertussis infection; 130 (87%) reported respiratory illness." | 1.27 | Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. ( Adkins, WN; Berg, J; Burstyn, DG; Davis, JP; Hopfensperger, D; Manclark, CR; Schell, WL; Steketee, RW; Wassilak, SG, 1988) |
| " Data were excluded for patients who required dosage adjustments because of toxicity or seizures." | 1.27 | Effect of influenza vaccine on serum anticonvulsant concentrations. ( Fidone, GS; Jann, MW, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (40.30) | 18.7374 |
| 1990's | 21 (31.34) | 18.2507 |
| 2000's | 7 (10.45) | 29.6817 |
| 2010's | 10 (14.93) | 24.3611 |
| 2020's | 2 (2.99) | 2.80 |
| Authors | Studies |
|---|---|
| Bjørk, MH | 1 |
| Zoega, H | 1 |
| Leinonen, MK | 1 |
| Cohen, JM | 1 |
| Dreier, JW | 2 |
| Furu, K | 1 |
| Gilhus, NE | 1 |
| Gissler, M | 1 |
| Hálfdánarson, Ó | 1 |
| Igland, J | 1 |
| Sun, Y | 2 |
| Tomson, T | 1 |
| Alvestad, S | 1 |
| Christensen, J | 2 |
| Li, Y | 1 |
| Zhang, T | 1 |
| Li, B | 1 |
| Li, J | 1 |
| Wang, L | 1 |
| Jiang, Z | 1 |
| Daugaard, CA | 1 |
| Pedersen, L | 1 |
| Mir, A | 1 |
| Chaudhary, M | 1 |
| Alkhaldi, H | 1 |
| Alhazmi, R | 1 |
| Albaradie, R | 1 |
| Housawi, Y | 1 |
| Baek, JH | 1 |
| Seo, YH | 1 |
| Kim, GH | 1 |
| Kim, MK | 1 |
| Eun, BL | 1 |
| Weaver, D | 1 |
| Chorny, V | 1 |
| Tewari, S | 1 |
| Moses, L | 1 |
| Katz, N | 1 |
| Weizman, A | 1 |
| Kim, SJ | 1 |
| Sohn, YB | 1 |
| Park, SW | 1 |
| Jin, DK | 1 |
| Paik, KH | 1 |
| Visser, WE | 1 |
| de Rijke, YB | 1 |
| van Toor, H | 1 |
| Visser, TJ | 1 |
| Yamada, K | 1 |
| Mano, T | 1 |
| Toribe, Y | 1 |
| Yanagihara, K | 1 |
| Suzuki, Y | 1 |
| Blumkin, L | 1 |
| Suls, A | 1 |
| Deconinck, T | 1 |
| De Jonghe, P | 1 |
| Linder, I | 1 |
| Kivity, S | 1 |
| Dabby, R | 1 |
| Leshinsky-Silver, E | 1 |
| Lev, D | 1 |
| Lerman-Sagie, T | 1 |
| Miyajima, T | 1 |
| Kumada, T | 1 |
| Saito, K | 1 |
| Fujii, T | 1 |
| Verhoeven, WM | 1 |
| Egger, JI | 1 |
| Cohen-Snuijf, R | 1 |
| Kant, SG | 1 |
| de Leeuw, N | 1 |
| Premachandra, BN | 1 |
| Radparvar, A | 1 |
| Burman, K | 1 |
| Williams, IK | 1 |
| Gaily, E | 2 |
| Kantola-Sorsa, E | 1 |
| Hiilesmaa, V | 1 |
| Isoaho, M | 1 |
| Matila, R | 1 |
| Kotila, M | 1 |
| Nylund, T | 1 |
| Bardy, A | 1 |
| Kaaja, E | 1 |
| Granström, ML | 2 |
| Tomka-Hoffmeister, M | 1 |
| Huber, B | 1 |
| Seidel, M | 1 |
| Zdrojewicz, Z | 1 |
| Dubiński, A | 1 |
| Jonek, A | 1 |
| Tomanek, N | 1 |
| Krajewski, W | 1 |
| Soultanian, C | 1 |
| Perisse, D | 1 |
| Révah-Levy, A | 1 |
| Luque, R | 1 |
| Mazet, P | 1 |
| Cohen, D | 1 |
| Rapport, MD | 1 |
| Sonis, WA | 1 |
| Fialkov, MJ | 1 |
| Matson, JL | 1 |
| Kazdin, AE | 1 |
| Singh, NN | 1 |
| Winton, AS | 1 |
| Bennett, HS | 1 |
| Dunlop, T | 1 |
| Ziring, P | 1 |
| Rajantie, J | 1 |
| Lamberg-Allardt, C | 2 |
| Wilska, M | 2 |
| Smith, MR | 1 |
| Sørrig, K | 1 |
| Lawless, LM | 1 |
| DeMonaco, HJ | 1 |
| Muido, LR | 1 |
| Reid, AH | 1 |
| Naylor, GJ | 1 |
| Kay, DS | 1 |
| Steckler, TL | 1 |
| Brodtkorb, E | 1 |
| Sand, T | 1 |
| Strandjord, RE | 1 |
| Koide, H | 1 |
| Shime, H | 1 |
| Velkey, I | 1 |
| Lombay, B | 1 |
| Murali, MV | 1 |
| Sharma, PP | 1 |
| Koul, PB | 1 |
| Gupta, P | 1 |
| Gigli, GL | 1 |
| Scalise, A | 1 |
| Silvestri, G | 1 |
| Diomedi, M | 1 |
| Placidi, F | 1 |
| Pomponi, MG | 1 |
| Masala, C | 1 |
| Ornoy, A | 1 |
| Cohen, E | 1 |
| Davanzo, PA | 1 |
| King, BH | 1 |
| Waisburg, H | 1 |
| Alvarez, N | 1 |
| Liukkonen, E | 1 |
| Vanstraelen, M | 1 |
| Tyrer, SP | 1 |
| Kelly, BD | 1 |
| Hillery, J | 1 |
| Helmchen, H | 1 |
| Bambrick, M | 1 |
| Wilson, D | 1 |
| Smith, DA | 1 |
| Perry, PJ | 1 |
| Mayhew, LA | 1 |
| Hanzel, TE | 1 |
| Ferron, FR | 1 |
| Kalachnik, JE | 1 |
| Harder, SR | 1 |
| Kastner, T | 2 |
| Friedman, DL | 2 |
| Pond, WS | 1 |
| Plummer, AT | 1 |
| Ruiz, MQ | 1 |
| Henning, D | 1 |
| Winchel, RM | 1 |
| Stanley, M | 1 |
| Kaski, M | 1 |
| Heinonen, E | 1 |
| Sivenius, J | 1 |
| Tuominen, J | 1 |
| Anttila, M | 1 |
| Vestermark, V | 1 |
| Vestermark, S | 1 |
| Laminack, L | 1 |
| Saraste, KL | 1 |
| Grönlund, T | 1 |
| Glue, P | 1 |
| Aman, MG | 2 |
| Teehan, CJ | 1 |
| White, AJ | 1 |
| Turbott, SH | 1 |
| Vaithianathan, C | 1 |
| Loonen, AJ | 1 |
| Toll, PJ | 1 |
| Nijdam, JR | 1 |
| Langee, HR | 1 |
| Deutsch, SI | 1 |
| Philippart, M | 1 |
| Buck, OD | 1 |
| Havey, P | 1 |
| Sheppard, LC | 1 |
| Ballinger, BR | 1 |
| Fenton, GW | 1 |
| Steketee, RW | 1 |
| Wassilak, SG | 1 |
| Adkins, WN | 1 |
| Burstyn, DG | 1 |
| Manclark, CR | 1 |
| Berg, J | 1 |
| Hopfensperger, D | 1 |
| Schell, WL | 1 |
| Davis, JP | 1 |
| Bhatia, MS | 1 |
| Singhal, PK | 1 |
| Kaur, N | 1 |
| Paxton, JW | 1 |
| Field, CJ | 1 |
| Foote, SE | 1 |
| Jann, MW | 1 |
| Fidone, GS | 1 |
| Signer, SF | 1 |
| Benson, DF | 1 |
| Rudnick, FD | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Schlack, HG | 1 |
| Vogt, HJ | 1 |
| Kauko, K | 1 |
| Tammisto, P | 1 |
| Kivalo, E | 1 |
| Seppäläinen, AM | 1 |
| Lydecken, K | 1 |
| Houben, PF | 1 |
| Hommes, OR | 1 |
| Knaven, PJ | 1 |
| dos Reis, MA | 1 |
7 reviews available for carbamazepine and Intellectual Disability
| Article | Year |
|---|---|
A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report.
Topics: Brain Diseases; Carbamazepine; China; Chronic Disease; Female; Humans; Intellectual Disability; Magn | 2019 |
Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10.
Topics: Anticonvulsants; Brain; Carbamazepine; Cerebellar Ataxia; Child; Child, Preschool; Epilepsy; Female; | 2019 |
Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Drug | 1994 |
Carbamazepine in the treatment of epilepsy in people with intellectual disability.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Intellectual Disability | 1998 |
Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Down Syndrome; Humans; Intellectual Disability; L | 1999 |
Nonneuroleptic treatment of disruptive behavior in organic mental syndromes.
Topics: Adrenergic beta-Antagonists; Antisocial Personality Disorder; Autistic Disorder; Carbamazepine; Deme | 1992 |
Self-injurious behavior: a review of the behavior and biology of self-mutilation.
Topics: Adolescent; Adult; Behavior Therapy; Biomarkers; Borderline Personality Disorder; Carbamazepine; Chi | 1991 |
8 trials available for carbamazepine and Intellectual Disability
| Article | Year |
|---|---|
Apparent increase in type I 5'-deiodinase activity induced by antiepileptic medication in mentally retarded subjects.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Hormones; Humans; Intellectual Disability; Iodide Per | 2002 |
Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Follow-Up Studies; Hu | 1998 |
Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
Topics: Adolescent; Adult; Carbamazepine; Child; Delayed-Action Preparations; Double-Blind Method; Drug Admi | 1991 |
Rapid cycling affective disorders in the mentally retarded.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Female; | 1989 |
Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
Topics: Adolescent; Adult; Behavior Therapy; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Me | 1989 |
A comparison of carbamazepine divitabs with carbamazepine normal formulation in psychiatric and oligophrenic patients. Preliminary pharmacokinetic results.
Topics: Adult; Aged; Carbamazepine; Delayed-Action Preparations; Female; Humans; Intellectual Disability; Ma | 1989 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
[Treatment of the agitated and most severe cases of cerebral injury and cerebral palsy with carbamazepin (Tegretol)].
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Cerebral Palsy; Child; Clinical T | 1968 |
52 other studies available for carbamazepine and Intellectual Disability
| Article | Year |
|---|---|
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
Topics: Anticonvulsants; Autism Spectrum Disorder; Autistic Disorder; Carbamazepine; Child; Cohort Studies; | 2022 |
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Denmark; Developmen | 2020 |
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Pr | 2014 |
Case 1: Joint Pain, Weight Loss, Fatigue, and Persistent Pleural Effusions in 17-year-old Boy.
Topics: Adolescent; Anticonvulsants; Arthralgia; Asthma; Carbamazepine; Diabetes Mellitus, Type 2; Diagnosis | 2015 |
Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities.
Topics: Adult; Anticonvulsants; Autism Spectrum Disorder; Blood Glucose; Body Mass Index; Carbamazepine; Cho | 2015 |
Chronic peritoneal dialysis in a 4-year-old boy with Lesch-Nyhan disease.
Topics: Allopurinol; Carbamazepine; Child, Preschool; DNA Mutational Analysis; Erythrocytes; Family Health; | 2009 |
Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cohort Studies; Cross-Sectional Studies; Drug Therapy, | 2011 |
MRI findings and steroid therapy for neuralgic amyotrophy in children.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Brachial Plexus Neuritis; Carbamazepine; Child; Child, Pr | 2011 |
Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation.
Topics: Adult; Anticonvulsants; Carbamazepine; Developmental Disabilities; Dyskinesias; Electroencephalograp | 2012 |
Autism in siblings with autosomal dominant nocturnal frontal lobe epilepsy.
Topics: Adolescent; Anticonvulsants; Asperger Syndrome; Autistic Disorder; Carbamazepine; Child; Child Devel | 2013 |
Phelan-McDermid syndrome: clinical report of a 70-year-old woman.
Topics: Aged; Butyrophenones; Carbamazepine; Carrier Proteins; Choline Kinase; Chromosome Deletion; Chromoso | 2013 |
Normal intelligence in children with prenatal exposure to carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; | 2004 |
[Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient].
Topics: Anticonvulsants; Carbamazepine; Dementia; Electroencephalography; Epilepsy; Humans; Intellectual Dis | 2004 |
Tetanic crisis and antiepileptic drugs. A case report.
Topics: Adult; Anticonvulsants; Calcium; Carbamazepine; Epilepsy, Tonic-Clonic; Female; Humans; Hypocalcemia | 2005 |
Cotard's syndrome in adolescents and young adults: a possible onset of bipolar disorder requiring a mood stabilizer?
Topics: Adolescent; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Body Image; Carbamazepine; Delusion | 2005 |
Carbamazepine and behavior therapy for aggressive behavior. Treatment of a mentally retarded, postencephalitic adolescent with seizure disorder.
Topics: Adolescent; Aggression; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Encephalitis; Ep | 1983 |
Behavioral monitoring of pharmacological interventions for self-injury.
Topics: Adolescent; Behavior; Behavior Therapy; Carbamazepine; Chlorpromazine; Circadian Rhythm; Humans; Int | 1984 |
Reduction of polypharmacy for epilepsy in an institution for the retarded.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Huma | 1983 |
Does carbamazepine treatment lead to a need of extra vitamin D in some mentally retarded children?
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcifediol; Calcium; Carbamazepine; Child; Female; Humans; | 1984 |
[Drug utilization in Sundbyvang: do 13 patient receive 200 mg of Tegretol twice a day].
Topics: Anticonvulsants; Carbamazepine; Denmark; Drug Utilization; Humans; Intellectual Disability; Resident | 1982 |
Protein binding of carbamazepine in epileptic patients.
Topics: Carbamazepine; Epilepsy; Humans; Intellectual Disability; Protein Binding | 1982 |
A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Double-Blind Method | 1981 |
Neuroleptic and antiepileptic treatment in the mentally retarded.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; | 1993 |
West syndrome with cerebellar porencephalus.
Topics: Age of Onset; Carbamazepine; Cerebellar Diseases; Child; Child, Preschool; Cysts; Electroencephalogr | 1993 |
[Rasmussen syndrome].
Topics: Acyclovir; Carbamazepine; Child, Preschool; Electroencephalography; Encephalitis; Epilepsies, Partia | 1993 |
Carbamazepine therapy for infantile tremor syndrome.
Topics: Carbamazepine; Child, Preschool; Humans; Infant; Intellectual Disability; Male; Pigmentation Disorde | 1993 |
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Chromoso | 1996 |
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child Development; Child, Preschool; Cr | 1996 |
Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy; Fear; Female; Follow-Up Studies; Humans; Intel | 1996 |
Hyponatremia during carbamazepine therapy in patients with intellectual disability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbamazepine; Child; Dose-Response Relationship, Drug; | 2001 |
[Psychiatric prognosis in epilepsies].
Topics: Affective Symptoms; Carbamazepine; Chronic Disease; Epilepsy; Humans; Intellectual Disability; Neuro | 1979 |
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1992 |
Phenobarbital exacerbation of self-injurious behavior.
Topics: Acute Disease; Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hu | 1992 |
Carbamazepine-induced hyponatremia in patients with mental retardation.
Topics: Carbamazepine; Drug Therapy, Combination; Humans; Hyponatremia; Intellectual Disability; Sodium | 1992 |
Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Female; Humans; | 1992 |
Teratogenic effect of carbamazepine.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Facial Bones; Female; Humans; Infant, N | 1991 |
Carbamazapine for behavioral disorders.
Topics: Carbamazepine; Electroencephalography; Epilepsy; Humans; Intellectual Disability; Neurocognitive Dis | 1990 |
Vitamin D status of ambulatory and nonambulatory mentally retarded children with and without carbamazepine treatment.
Topics: Adolescent; Adult; Calcifediol; Calcitriol; Carbamazepine; Diet; Eating; Exercise; Humans; Intellect | 1990 |
A retrospective study of mentally retarded patients with behavioral disorders who were treated with carbamazapine.
Topics: Carbamazepine; Electroencephalography; Humans; Intellectual Disability; Mental Disorders; Retrospect | 1989 |
Managing behavior in mentally retarded residential populations.
Topics: Adrenergic beta-Antagonists; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Institutionali | 1986 |
Clinical recognition of Rett syndrome.
Topics: Adolescent; Autistic Disorder; Carbamazepine; Child; Child, Preschool; Diagnosis, Differential; Fema | 1986 |
Combined carbamazepine and lithium therapy for violent behavior.
Topics: Adult; Aggression; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Humans; Intellectual Di | 1986 |
Anticonvulsant medication in a mental handicap hospital: 1972-1982.
Topics: Anticonvulsants; Carbamazepine; Female; Hospitals, Psychiatric; Humans; Intellectual Disability; Mal | 1987 |
Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Diphtheria Toxoid; Diphtheria-Tetanus-Per | 1988 |
Psychosis associated with anticonvulsant toxicity.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Humans; Intellectual Disability; Male; Phenytoin; | 1987 |
Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Intellectual Disability; Kinetics; Male; Phenytoin; | 1986 |
Effect of influenza vaccine on serum anticonvulsant concentrations.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Influenza Vaccines; Inf | 1986 |
Undetected affective disorder in the developmentally retarded.
Topics: Adult; Carbamazepine; Depressive Disorder; Humans; Intellectual Disability; Male; Mood Disorders | 1986 |
[Development inhibition in brain-damaged children due to anticonvulsants].
Topics: Anticonvulsants; Carbamazepine; Child; Child Development; Electroencephalography; Humans; Intellectu | 1973 |
Comparison of two generically equivalent carbamazepine preparations.
Topics: Adolescent; Adult; Biopharmaceutics; Blood-Brain Barrier; Carbamazepine; Child; Epilepsy; Half-Life; | 1974 |
Anticonvulsant drugs and folic acid in young mentally retarded epileptic patients. A study of serum folate, fit frequency and I.Q.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Ethosuximide; Female; Folic Acid; Human | 1971 |
[Use of "Tegretol" in cerebral disrhythmies].
Topics: Adolescent; Adult; Carbamazepine; Dibenzazepines; Female; Humans; Intellectual Disability; Male; Sei | 1968 |